Table 1.

Demographic and clinical characteristics of study cohort (n = 106).

	Overall
	n (%)
Age
0– <1 year	12 (11.3%)
1– <2 years	6 (5.7%)
2– <5 years	30 (28.3%)
5– <13 years	28 (26.4%)
13–21years	30 (28.3%)
Sex
Male	63 (59.4%)
Female	43 (40.6%)
Diagnosis
Leukemia/lymphoma	40 (37.7%)
Solid tumor	29 (27.4%)
Primary immunodeficiency	14 (13.2%)
Metabolic disorder	7 (6.6%)
Aplastic anemia/inherited bone marrow failure	6 (5.7%)
Myelodysplastic syndrome	4 (3.8%)
Hemoglobinopathy	3 (2.8%)
Other	3 (2.8%)
Transplant type
Allogeneic	70 (66%)
Autologous	36 (34%)